|2.75||+0.12 / +4.56%|
As of 3:59pm ET
|2.95||+0.20 / +7.27%|
The 3 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +990.91% increase from the last price of 2.75.
The current consensus among 3 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.